Mo1873 WHICH SECOND-LINE BIOLOGIC AFTER ANTI-TNF FAILURE DURING CROHN'S DISEASE: USTEKINUMAB OR VEDOLIZUMAB, A MULTICENTRE RETROSPECTIVE STUDY
| Autor: | Rayer, Cassandra, Roblin, Xavier, Laharie, David, Flamant, Mathurin, Dewitte, Marie, Fumery, Mathurin, Caron, Benedicte, Viennot, Stephanie, Pariente, Benjamin, Laurent, Siproudhis, Peyrin-Biroulet, Laurent, Bouguen, Guillaume |
|---|---|
| Zdroj: | In Gastroenterology May 2020 158(6) Supplement 1:S |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|